An experimental Alzheimer’s drug has been shown to slow significantly the cognitive and functional decline linked to the disease in results hailed as “remarkable” by experts, despite some patients experiencing serious side effects. United States pharmaceutical giant Eli Lilly announced on Wednesday that in a late-stage trial of nearly 1,200 people in the early stages of Alzheimer’s disease, the drug, donanemab, slowed the progression of symptoms by 35 percent over a period of 18 months compared with a placebo. Al Jazeera’s John Hendren reports. Subscribe to our channel: http://bit.ly/AJSubscribe Follow us on Twitter https://twitter.com/AJEnglish Find us on Facebook https://www.facebook.com/aljazeera Check our website: http://www.aljazeera.com/ Check out our Instagram page: https://www.instagram.com/aljazeeraenglish/ #Alzheimers […]
#FDA #EliLilly #alzheimer #yahoofinance Yahoo Finance Live anchors Dave Briggs and Seana Smith discuss the move lower in Eli Lilly stock. Don’t Miss: Valley of Hype: The culture that built Elizabeth Holmes WATCH HERE: Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. Yahoo Finance Plus: With a subscription to Yahoo Finance Plus get the tools you need to invest with confidence. Discover new opportunities with expert research and investment ideas backed by technical and fundamental analysis. Optimize your trades with advanced portfolio […]
The drug makers announced it was pausing the trial “out of an abundance of caution” amid new potential safety concerns. The move comes just hours after Johnson & Johnson announced it was also pausing its trials because a participant suffered an “unexplainable illness.” » Subscribe to NBC News: http://nbcnews.to/SubscribeToNBC » Watch more NBC video: http://bit.ly/MoreNBCNews NBC News Digital is a collection of innovative and powerful news brands that deliver compelling, diverse and engaging news stories. NBC News Digital features NBCNews.com, MSNBC.com, TODAY.com, Nightly News, Meet the Press, Dateline, and the existing apps and digital extensions of these respective properties. We deliver the best in breaking news, live video coverage, original […]
